Nihon Kohden (OTCMKTS:NHNKY) Stock Price Down 3.6% - Should You Sell?

Key Points

• Nihon Kohden's stock price declined by 3.6%, closing at $11.56 after trading as low as $11.48.
• The company reported a quarterly revenue of $346.24 million with an earnings per share (EPS) of $0.01, resulting in a return on equity of 6.74%.
• Nihon Kohden has a market capitalization of $2.02 billion and a P/E ratio of 21.87, with its stock exhibiting lower trading volume—approximately 657 shares—which is an 88% decrease from its average daily volume.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) was down 3.6% during trading on Thursday . The stock traded as low as $11.48 and last traded at $11.56. Approximately 657 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 5,682 shares. The stock had previously closed at $11.99.

Nihon Kohden Stock Down 1.5%

The firm has a 50 day moving average price of $11.69 and a 200 day moving average price of $12.44. The stock has a market cap of $2.02 billion, a P/E ratio of 21.87 and a beta of 0.40.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.01 EPS for the quarter. Nihon Kohden had a return on equity of 6.74% and a net margin of 5.77%.The firm had revenue of $346.24 million for the quarter.

About Nihon Kohden

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.